Regions Financial Corp’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-5,661
| Closed | -$286K | – | 1057 |
|
|
2019
Q1 | $286K | Buy |
5,661
+167
| +3% | +$8.44K | ﹤0.01% | 678 |
|
|
2018
Q4 | $326K | Sell |
5,494
-1,776
| -24% | -$105K | ﹤0.01% | 614 |
|
|
2018
Q3 | $479K | Sell |
7,270
-249
| -3% | -$16.4K | 0.01% | 576 |
|
|
2018
Q2 | $380K | Sell |
7,519
-2,007
| -21% | -$101K | ﹤0.01% | 627 |
|
|
2018
Q1 | $501K | Sell |
9,526
-3,128
| -25% | -$165K | 0.01% | 565 |
|
|
2017
Q4 | $588K | Sell |
12,654
-12,505
| -50% | -$581K | 0.01% | 540 |
|
|
2017
Q3 | $1.02M | Sell |
25,159
-2,752
| -10% | -$111K | 0.01% | 421 |
|
|
2017
Q2 | $946K | Sell |
27,911
-28,245
| -50% | -$957K | 0.01% | 447 |
|
|
2017
Q1 | $1.63M | Sell |
56,156
-3,538
| -6% | -$103K | 0.02% | 355 |
|
|
2016
Q4 | $1.96M | Buy |
59,694
+5,747
| +11% | +$189K | 0.02% | 303 |
|
|
2016
Q3 | $1.7M | Buy |
53,947
+9,014
| +20% | +$284K | 0.02% | 333 |
|
|
2016
Q2 | $1.26M | Buy |
44,933
+6,632
| +17% | +$187K | 0.02% | 432 |
|
|
2016
Q1 | $1.39M | Sell |
38,301
-12,444
| -25% | -$452K | 0.02% | 414 |
|
|
2015
Q4 | $2.03M | Sell |
50,745
-6,081
| -11% | -$243K | 0.03% | 304 |
|
|
2015
Q3 | $1.62M | Buy |
56,826
+6,845
| +14% | +$195K | 0.02% | 362 |
|
|
2015
Q2 | $1.65M | Sell |
49,981
-3,172
| -6% | -$105K | 0.02% | 376 |
|
|
2015
Q1 | $1.53M | Buy |
53,153
+1,679
| +3% | +$48.3K | 0.02% | 404 |
|
|
2014
Q4 | $1.4M | Buy |
51,474
+528
| +1% | +$14.4K | 0.02% | 425 |
|
|
2014
Q3 | $1.09M | Buy |
50,946
+2,059
| +4% | +$43.9K | 0.01% | 562 |
|
|
2014
Q2 | $1.1M | Buy |
48,887
+9,083
| +23% | +$204K | 0.01% | 566 |
|
|
2014
Q1 | $1.01M | Buy |
+39,804
| New | +$1.01M | 0.01% | 576 |
|